Cargando…
A review on in silico virtual screening methods in COVID-19 using anticancer drugs and other natural/chemical inhibitors
The present coronavirus disease 2019 (COVID-19) pandemic scenario has posed a difficulty for cancer treatment. Even under ideal conditions, malignancies like small cell lung cancer (SCLC) are challenging to treat because of their fast development and early metastases. The treatment of these patients...
Autor principal: | Sokouti, Babak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651357/ https://www.ncbi.nlm.nih.gov/pubmed/38023988 http://dx.doi.org/10.37349/etat.2023.00177 |
Ejemplares similares
-
In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
por: Gagic, Zarko, et al.
Publicado: (2020) -
In silico drug discovery of SIRT2 inhibitors from natural source as anticancer agents
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2023) -
Virtual Screening of Natural Chemical Databases to Search for Potential ACE2 Inhibitors
por: Yao, Huiping
Publicado: (2022) -
Machine Learning for In Silico Virtual Screening and Chemical Genomics: New Strategies
por: Vert, Jean-Philippe, et al.
Publicado: (2008) -
Virtual screening and in silico design of novel inhibitors of bacterial lectins
por: Alán, Jan, et al.
Publicado: (2012)